Scholar Rock Holding Corporation

Healthcare · Biotechnology · United States

Last price 44.18 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 5.38B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. The company’s novel understanding of the molecular mechanisms of growth factor activation within the transforming growth factor beta (TGFβ) superfamily has enabled the development of a proprietary platform. This platform is used for the development of monoclonal antibodies that locally and selectively target the precursor, or laten...